P53 mutation, deprivation and poor prognosis in primary breast cancer

British Journal of Cancer

Volumn 102, Issue 4, 2010, Pages 719-726

  Baker, L ^a   Quinlan, P R ^a   Patten, N ^b   Ashfield, A ^a   Birse Stewart Bell, L J ^a   McCowan, C ^a   Bourdon, J C ^a   Purdie, C A ^a   Jordan, L B ^a   Dewar, J A ^a   Wu, L ^b   Thompson, A M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

Disease free survival; Overall survival; P53; Primary breast cancer; Socio economic deprivation

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORBIDITY; OVERALL SURVIVAL; PATHOLOGY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SOCIAL STATUS; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; HUMANS; MIDDLE AGED; MUTATION; PROGNOSIS; PSYCHOSOCIAL DEPRIVATION; SOCIAL CLASS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 76949102285     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605540     Document Type: Article

References (29)

1. Al Murri AM, Doughty JC, Lannigan A, Wilson C, McArdle CS, McMillan DC (2004) The relationship between deprivation, tumour stage and the systemic inflammatory response in patients with primary operable breast cancer. Br J Cancer 91(6): 1063-1065
2. Banks J, Marmot M, Oldfield Z, Smith JP (2006) Disease and disadvantage in the United States and in England. JAMA 295: 2037-2045
3. Bishop J, Clark D, Harris V, Stockton D, Sutton M (2004) Deprivation and Urban Rural Measurement in ISD. Edinburgh. http://www.isdscotland.org/isd/files/ Measuring-deprivation-in-ISD-v3-pdf
4. Bloom H, Richardson W (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3): 359-377
5. Carstairs V, Morris R (1991) Deprivation and health in Scotland. University Press: Aberdeen
6. Detre S, Saclani Jotti G, Dowsett M (1995) A 'quickscore' method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48(9): 876-878
7. Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, Jhappan C, Higashimoto Y, He P, Linke SP, Quezado MM, Zurer I, Rotter V, Wink DA, Appella E, Harris CC (2003) Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 100: 143-148
8. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 60: 3333-3337
9. Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121(11): 2373-2380
10. Kelsey JL, Fischer DB, Holford TR, LiVoisi VA, Mostow ED, Goldenberg IS, White C (1981) Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst 67(2): 327-333
11. Kogevinas M, Porta M (1997) Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ 138: 177-206
12. MacKie RM, Hole DJ (1996) Incidence and thickness of primary tumours and survival of patients with malignant melanoma in relation to socioeconomic status. Br Med J 312: 1125-1128
13. McMillan DC, Canna K, McArdle CS (2003) The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer. Br J Cancer 89: 612-614 (Pubitemid 37076160)
14. Mullee MA, De Stavola B, Romanengo M, Coleman MP (2004) Geographical variation in breast cancer survival rates for women diagnosed in England between 1992 and 1994. Br J Cancer 90(11): 2153-2156
15. Olivier M, Langerød A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bièche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Børreson-Dale A-L (2006) The clinical value of somatic TP53 gene mutations in 1794 patients with breast cancer. Clin Cancer Res 12(4): 1157-1167
16. O'Reilly DStJ, Upton MN, Caslaske MJ, Robertson M, Norrie J, McConnachie A, Watt GCM, Packard CJ (2006) on behalf of the Midspan and WOSCOPS study groups. Plasma C reactive protein concentration indicates a direct relation between systemic inflammation and social deprivation. Heart 92(4): 533-535
17. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorenson BE, McTiernan A, Ulrich CM (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27(21): 3437-3444
18. Quinn MJ, Cooper N, Rachet B, Mitry E, Coleman MP (2008) Survival from cancer of the breast in women in England and Wales up to 2001. Br J Cancer 99(SUPPL. 1): S53-S55
19. Ridker PM, Hennekens CH, Buring J, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843 (Pubitemid 30165206)
20. Sant M, Capocaccia R, Verdecchia A, Estève J, Gatta G, Micheli A, Coleman MP, Berrino F (1998) Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer 77: 679-683
21. Schrijvers CT, Mackenbach JP, Lutz JM, Quinn MJ, Coleman MP (1995) Deprivation and survival from breast cancer. Br J Cancer 72: 738-743
22. Schrijvers CT, Coebergh JW, Mackenbach JP (1997) Socioeconomic status and comorbidity among newly diagnosed cancer patients. Cancer 80: 1482-1488
23. Staib F, Robles AI, Varticovski L, Wang XW, Zeeberg BR, Sirotin M, Zhurkin VB, Hofseth LJ, Hussain SP, Weinstein JN, Galle PR, Harris CC (2005) The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res 65: 10255-10264
24. Staples O, Lain S, Ziyaie D, Thompson AM (2008) p53 and breast cancer. In: Walker RA, Thompson AM, editors Prognostic and predictive factors in breast cancer 2nd ed, pp 148-167. Informa Healthcare: London, UK
25. Taylor A, Cheng KK (2003) Social deprivation and breast cancer. J Public Health Med 25: 228-233
26. Thomson CS, Hole DJ, Twelves C, Brewster DH, Black RJ (2001) Prognostic factors in women with breast cancer: distribution by socio-economic status and effect on differences in survival. J Epidemiol Community Health 55: 308-315
27. Thomson CS, Brewster DH, Dewar JA, Twelves CJ (2004) on behalf of the Scottish Cancer Therapy Network. Improvements in survival for women with breast cancer in Scotland between 1987 and 1993: impact of earlier diagnosis and changes in treatment. Eur J Cancer 40(5): 743-753
28. Twelves CJ, Thomson CS, Dewar JA, Brewster DH (2001) Variation in survival of women with breast cancer: Health Board remains a factor at ten years. Br J Cancer 85: 637-640
29. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283